Assoicated Medical Conditions for Schizophrenia

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteris in To
Acne 36.8 % 7 19 93
ADHD 34 % 16 47 93
Allergic Rhinitis (Hay Fever) 27.8 % 10 36 93
Allergies 30 % 15 50 93
Alzheimer's disease 30 % 15 50 93
Amyotrophic lateral sclerosis (ALS) Motor Neuron 30.2 % 13 43 93
Ankylosing spondylitis 34.4 % 32 520 93
Asthma 29.6 % 8 27 93
Atherosclerosis 37.6 % 35 524 93
Autism 31.2 % 29 110 93
Barrett esophagus cancer 12.5 % 2 16 93
Bipolar Disorder 48.5 % 16 33 93
Brain Trauma 31.8 % 7 22 93
Carcinoma 29.4 % 15 51 93
Celiac Disease 17.9 % 12 67 93
Cerebral Palsy 52.9 % 9 17 93
Chronic Fatigue Syndrome 20 % 11 55 93
Chronic Kidney Disease 28.6 % 10 35 93
Chronic Urticaria (Hives) 26.1 % 6 23 93
Colorectal Cancer 24.7 % 23 296 93
Coronary artery disease 12.5 % 2 16 93
COVID-19 16.7 % 6 36 93
Crohn's Disease 33.3 % 31 141 93
cystic fibrosis 14.3 % 1 7 93
Depression 33.3 % 27 81 93
Epilepsy 32 % 8 25 93
Fibromyalgia 18.9 % 7 37 93
Functional constipation / chronic idiopathic constipation 39 % 16 41 93
gallstone disease (gsd) 33.3 % 5 15 93
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 16.7 % 4 24 93
Gout 19 % 4 21 93
Graves' disease 62.5 % 5 8 93
Hashimoto's thyroiditis 28.6 % 4 14 93
High Blood Pressure 19.1 % 9 47 93
Histamine Issues 13.3 % 4 30 93
hypercholesterolemia (High Cholesterol) 22.2 % 2 9 93
Hyperlipidemia (High Blood Fats) 16 % 4 25 93
hypertension (High Blood Pressure 50 % 3 6 93
IgA nephropathy (IgAN) 20.7 % 6 29 93
Inflammatory Bowel Disease 25.8 % 17 66 93
Insomnia 80 % 8 10 93
Irritable Bowel Syndrome 29 % 18 62 93
Liver Cirrhosis 39.8 % 37 678 93
ME/CFS with IBS 21.1 % 4 19 93
ME/CFS without IBS 19.2 % 5 26 93
Metabolic Syndrome 14.3 % 1 7 93
Mood Disorders 33.3 % 2 6 93
Multiple Sclerosis 30.1 % 28 100 93
Multiple system atrophy (MSA) 23.8 % 5 21 93
neuropsychiatric disorders (PANDAS, PANS) 20 % 3 15 93
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 21.1 % 16 76 93
Obesity 29.1 % 16 55 93
Obesity 12.9 % 12 104 93
Osteoporosis 31.8 % 7 22 93
Parkinson's Disease 28.9 % 26 90 93
Psoriasis 21.7 % 10 46 93
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 33.3 % 31 134 93
Rosacea 50 % 11 22 93
Sjögren syndrome 26.8 % 11 41 93
Small Intestinal Bacterial Overgrowth (SIBO) 25 % 4 16 93
Stress / posttraumatic stress disorder 28.6 % 16 56 93
Systemic Lupus Erythematosus 33.3 % 22 66 93
Type 1 Diabetes 28.8 % 15 52 93
Type 2 Diabetes 44.1 % 41 267 93
Ulcerative colitis 25.8 % 24 108 93

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.